ID   mel-Alx-LP
AC   CVCL_D2PW
DR   Wikidata; Q127382800
RX   Patent=RU2796357;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 812D.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Patent=RU2796357
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14,15
ST   D12S391: 20,21
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D1S1656: 12
ST   D21S11: 30,31
ST   D22S1045: 15
ST   D2S441: 11
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   SE33: 19
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
RX   Patent=RU2796357;
RA   Prosekina E.A., Murashkina A.A., Karpov A.E., Fedorutseva E.Y.,
RA   Artemeva A.S., Malek A.V.;
RT   "Human skin melanoma cell line mel-Alx-LP.";
RL   Patent number RU2796357, 22-May-2023.
//